OpenAlex
PricingAboutJobs
Log inGet started
Work

Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension

HTML

Year: 2019
Type: article
Study design: Clinical Trial
Source: Circulation
DOI: 10.1161/circulationaha.118.036568
Authors: Keith C. Ferdinand, Joseph L. Izzo, Jisoo Lee, Leslie Meng, Jyothis George, Afshin Salsali, Leo Seman
Institutions: Tulane University, University at Buffalo, State University of New York, Boehringer Ingelheim (Germany), Boehringer Ingelheim (China), Boehringer Ingelheim (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: empagliflozin, SGLT2 inhibitors, type 2 diabetes, hypertension, antihypertensive effect, glycemic control, glycohemoglobin, blood pressure reduction, weight loss, Black patients, ambulatory blood pressure, drug safety, adverse events, drug discontinuation, cardiovascular safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2917317410
FWCI: 7.948
Cites: 34
Cited by: 108
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security